These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17163831)

  • 1. Effect of tibolone therapy on lipids and coagulation indices.
    Daher R; Al-Amin H; Beaini M; Usta I
    Clin Chem Lab Med; 2006; 44(12):1498-9. PubMed ID: 17163831
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of 5-year therapy with tibolone on the lipid profile in postmenopausal women with mild hypercholesterolemia.
    Kalogeropoulos S; Petrogiannopoulos C; Gagos S; Kampas N; Kalogeropoulos G
    Gynecol Endocrinol; 2004 Apr; 18(4):227-32. PubMed ID: 15293895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women.
    Dansuk R; Unal O; Karageyim Y; Esim E; Turan C
    Gynecol Endocrinol; 2004 May; 18(5):233-9. PubMed ID: 15346658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study on the efficacy of tibolone in counteracting early carotid atherosclerotic lesions in postmenopausal women.
    Anedda FM; Velati A; Lello S; Orrù M; Paoletti AM; Melis GB; Binaghi F
    Horm Res; 2004; 61(1):47-52. PubMed ID: 14646402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia.
    Nóvoa FJ; Boronat M; Carrillo A; Tapia M; Díaz-Cremades J; Chirino R
    Horm Res; 2002; 57(5-6):187-91. PubMed ID: 12053091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the lipidic and coagulative pattern in postmenopause women: effect of hormone replacement therapy.
    Evola G; Novo G; Amoroso G; Guttilla D; Lo Coco L; Guagliardo M; Lupo A; Averna MR; Giambanco V; Miller V; Novo S
    Int Angiol; 2010 Aug; 29(4):355-61. PubMed ID: 20671654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
    Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.
    Milner MH; Sinnott MM; Cooke TM; Kelly A; McGill T; Harrison RF
    Obstet Gynecol; 1996 Apr; 87(4):593-9. PubMed ID: 8602314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK; Ahn JY; Jin DK; Yoon BK; Kim HS; Kim DS; Kang WC; Han SH; Choi IS; Shin EK
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1889-94. PubMed ID: 12933531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
    Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of megestrol acetate as an alternative to conventional hormone replacement therapy.
    Farish E; Barnes JF; O'Donoghue F; Fletcher CD; Ekevall K; Hart DM
    Climacteric; 2000 Jun; 3(2):125-34. PubMed ID: 11910653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
    Guazzelli CA; Lindsey PC; de Araújo FF; Barbieri M; Petta CA; Aldrighi JM
    Contraception; 2005 Feb; 71(2):118-21. PubMed ID: 15707561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause.
    Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R
    Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of tibolone and estrogen therapy on hemostasis in surgical menopause: a randomized, double-blind, placebo-controlled study.
    Demirol A; Guven S; Guvendag Guven ES; Kirazli S; Gurgan T; Ayhan A
    Fertil Steril; 2007 Apr; 87(4):842-8. PubMed ID: 17222829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux.
    von Eckardstein A; Crook D; Elbers J; Ragoobir J; Ezeh B; Helmond F; Miller N; Dieplinger H; Bennink HC; Assmann G
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):49-58. PubMed ID: 12519412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.